-
Friday, 10/24/2025
29th International Symposium On Infections In The Critically Ill Patients (ISICIP 2025)
-
Friday, 10/24/2025
Four Posters Presented at the ISICIP Congress in Barcelona - One Wins Best Poster Award.
Four Posters Presented at the ISICIP Congress in Barcelona ; One Wins Best Poster Award.
Four posters from our research group were selected for presentation at the ISICIP Congress, held on October 16–17 in Barcelona. Among them, one received the award for Best Poster of the Congress.
Members of our research team actively participated in the event, presenting their work and engaging with attendees.
The congress was once again organized by various members of the scientific community, including our group leader, Dr. Antoni Torres.
-
Thursday, 10/09/2025
European Researchers’ Night
European Researchers’ Night is a Europe-wide public event held annually in late September, aimed at bringing research and researchers closer to society. This year in Barcelona, Dr Laia Fernàndez-Barat and Dr Viviane de Cassia played an active role: Dr Fernàndez-Barat presented the homi-Lung project through an engaging video, while Dr de Cassia explored the topic of antibiotic resistance through a storytelling activity.
-
Monday, 09/01/2025
New fellow from Italy
Nicoletta Serra, MD
Resident in a Intensive Care Unit at University of Genoa (Italy).
Staying at IDIBAPS from September until March 2026.During her period at IDIBAPS, she will focus on critical care in respiratory medicine, especially on Non-Invasive Ventilation (NIV) and the impact of P-SILI in ARDS. She will also be involved in the ARDS animal model experiment.
-
Thursday, 06/26/2025
SOCAP Emerging Researcher Grant Awarded to Dr. Enric Barbeta Viñas
In the annual research grant call organized by the Catalan Society of Pulmonology (SOCAP), Dr. Enric Barbeta has been selected as one of the winners with his project titled: Physiological Effects of Two Non-Invasive Respiratory Support Strategies (Continuous Positive Airway Pressure vs. High Flow Nasal Cannula) in Patients with Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
-
Tuesday, 06/17/2025
Dr. Anna Motos Awarded the "Lección Joven" Prize at SEPAR 2025
Dr. Anna Motos Awarded the "Lección Joven" Prize at SEPAR 2025
We are proud to announce that Dr. Anna Motos Galera (Barcelona) has been honored with the "Lección Joven" award at the National Congress of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), held from June 12–15, 2025, in Bilbao, Spain.Dr. Motos delivered a keynote lecture in the basic science category titled:"From the Lab to the Clinic: An Integrated Vision of Nosocomial Pneumonia.Her session focused on the development and implementation of innovative strategies for managing nosocomial pneumonia, highlighting the full translational pathway—from laboratory research and animal models to clinical studies. The lecture was especially aimed at early-career researchers in both basic and clinical science fields, fostering interdisciplinary approaches to tackling hospital-acquired infections.Congratulations to Dr. Motos for this well-deserved recognition of her outstanding contributions to respiratory research! -
Tuesday, 06/17/2025
Dr. Viviane de Cássia Oliveira Wins Poster Presentation Award at Targeting Phage Therapy 2025
Dr. Viviane de Cássia Oliveira Wins Poster Presentation Award at Targeting Phage Therapy 2025.
We are proud to announce that Dr. Viviane de Cássia Oliveira, ARISTOS fellow, has received the "Poster Presentation Award 2025" at the 8th World Congress on Targeting Phage Therapy, held in Berlin, Germany.
Her award-winning study, titled "Evolution of ceftolozane/tazobactam resistance in carbapenem-resistant pseudomonas aeruginosa under phage-antibiotic pressure,"
addresses one of the most pressing issues in global health: antimicrobial resistance.The research revealed that combining phages with antibiotics can delay the development of resistance to ceftolozane/tazobactam in pseudomonas aeruginosa.
-
Friday, 04/25/2025
New fellow from Italy
-
Friday, 04/25/2025
Our group presents six posters at ECCMID 2025: science, innovation and connections in Vienna
The Applied Research in Respiratory Infections and Critical Illness group actively participated in the 2025 edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held in Vienna from April 12 to 15 — a key international event in the field.Our group presents six posters at ECCMID 2025: science, innovation and connections in ViennaThe Applied Research in Respiratory Infections and Critical Illness group actively participated in the 2025 edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held in Vienna from April 12 to 15 — a key international event in the field.Seven members —Roberto Cabrera Ortega, Catia Cillóniz, Viviane De Cassia, Laia Fernández-Barat, Kasra Kiarostami, Guillem Macip and Alba Soler— presented a total of six scientific posters.The topics included:- the dynamics of phage sensitivity in multidrug-resistant and non-resistant Pseudomonas aeruginosa (P2373),
- the effect of inhaled amikacin on biofilm viability in an experimental Pseudomonas-induced ventilator-associated pneumonia model (P3138),
- the impact of engineered Mycoplasma pneumoniae on P. aeruginosa biofilms and the respiratory microbiota (P2355),
- studies focused on the respiratory microbiome (P2201),
- research on microbial pathogenesis and virulence (P3378),
- and experimental and cellular microbiology (P3512).
In addition to presenting their work, the team connected with industry stakeholders, including Oxford Nanopore and companies focused on DNA extraction kits and phage synthesis, with an eye toward future collaborations. -
Thursday, 04/24/2025
Dr. Laia Fernández Awarded ALBERT AGUSTÍ Grant by FUCAP
Dr. Laia Fernández has been awarded the ALBERT AGUSTÍ Grant by the Catalan Society of Pulmonology (FUCAP).
The grant entitled "Eficàcia combinada dels antibiòtics i bacteriòfags per al tractament de la pneumònia associada a ventilació mecànica causada per Pseudomonas aeruginosa" has been endowed with €14,000. The decision was made on March 27 by the jury appointed by the Catalan Society of Pulmonology (FUCAP).




